Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.


Journal Article

This study was undertaken to determine the disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized clinical trial. Comparison of the 2 treatments, using either time-to-first evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.

Full Text

Duke Authors

Cited Authors

  • Paulson, DF; Cline, WA; Koefoot, RB; Hinshaw, W; Stephani, S

Published Date

  • May 1, 1982

Published In

Volume / Issue

  • 127 / 5

Start / End Page

  • 935 - 937

PubMed ID

  • 6806486

Pubmed Central ID

  • 6806486

International Standard Serial Number (ISSN)

  • 0022-5347

Digital Object Identifier (DOI)

  • 10.1016/s0022-5347(17)54136-1


  • eng

Conference Location

  • United States